FLEXSTAR
LIVE

Serial Number

79311993

Owner

altona Diagnostics GmbH

Attorney

Matthew J. Smith

Filing Date

Apr 21, 2021

Add to watchlist:

No watchlists yet
View on USPTO

FLEXSTAR Trademark

Serial Number: 79311993 • Registration: 7215162

FLEXSTAR is a trademark filed by altona Diagnostics GmbH on April 21, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

altona Diagnostics GmbH (6 trademarks)

Mörkenstraße 12

Entity Type: 99

Trademark Details

Filing Date

April 21, 2021

Registration Date

November 14, 2023

Published for Opposition

August 29, 2023

Goods & Services

Scientific apparatus and instruments for laboratory use and for the conducting and evaluation of diagnostic examinations for medical laboratory and scientific purposes, namely, thermocyclers, for marking, separating, isolating, purifying, amplifying, and analyzing biopolymers, in particular, nucleic acids, proteins, macro molecules and biologically active substances, for laboratory or research use and computer hardware and recorded computer operating software for scientific apparatus, instruments and equipment; scientific apparatus and instruments for laboratory use, for use in amplification procedures by use of polymerase chain reaction (PCR); plastic goods for laboratories, in particular microplates with and without reagents for laboratory use; lids for microplates; sealing foils for microplates; all the aforementioned goods for use in scientific research, clinical laboratory, medical research or non-medical diagnostic applications

Pharmaceutical and veterinary preparations, namely, biological substances and chemicals for use in medical purposes and medical in vitro diagnostics purposes, namely, nucleic acids, enzymes, polymerases, molecular probes, buffer, aqueous and non-aqueous solutions of alcohols and salts, distilled and purified water, silica in powdered, granulate and gel form, magnetic particles in fluid form; in-vitro diagnostic preparations for medical purposes; diagnostic preparations for medical purposes; enzymes and preparations being diagnostic preparations for polymerase chain reaction (PCR) for medical purposes; all the aforementioned goods for medical or veterinary purposes

Biological and chemical substances, for industrial, scientific and research purposes, namely, nucleic acids, enzymes, polymerases, reagents for staining or marking, molecular probes, buffer, aqueous and non-aqueous solutions of alcohols and salts, distilled and purified water, silica in powdered, granulate and gel form, and magnetic particles in fluid form, for laboratory and research use; enzymes and preparations for polymerase chain reaction (PCR) for chemical purposes; diagnostic preparations for scientific or research purposes; diagnostic substances in the nature of reagents for scientific or research purposes; all the aforementioned goods for industrial or scientific purposes

Scientific and technological services and research services, namely, scientific research, analysis and testing in the field of clinical, veterinary, environmental and medical diagnosis in the field of molecular biology; technological consultancy services for scientific, technical laboratory and research purposes, namely, technological consulting services in the field of scientific research laboratories and medical diagnostic laboratories; providing technical support services in the nature of troubleshooting problems with in vitro diagnostic laboratory instruments, laboratory automation systems and for related software and computer hardware; providing electronic remote debugging services being IT services for laboratories in the field of in vitro diagnostic laboratory instruments, laboratory automation systems and for related software

Filing History

LIMITATION OF GOODS RECEIVED FROM IB
Sep 11, 2025 LIMG
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 4, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 14, 2024 FICS
FINAL DISPOSITION PROCESSED
Feb 14, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 14, 2024 FICR
NEW REPRESENTATIVE AT IB RECEIVED
Jan 27, 2024 NREP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 14, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 14, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 29, 2023 NPUB
PUBLISHED FOR OPPOSITION
Aug 29, 2023 PUBO
NOTIFICATION PROCESSED BY IB
Aug 27, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 9, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 9, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 9, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 26, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 26, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 26, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 26, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 9, 2023 GNRN
NON-FINAL ACTION E-MAILED
Mar 9, 2023 GNRT
NON-FINAL ACTION WRITTEN
Mar 9, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 2, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 2, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 2, 2023 TROA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 20, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 2, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 2, 2022 OPNR
REFUSAL PROCESSED BY IB
Sep 5, 2022 RFNP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 15, 2022 GNRN
NON-FINAL ACTION E-MAILED
Aug 15, 2022 GNRT
NON-FINAL ACTION WRITTEN
Aug 15, 2022 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 8, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 8, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 8, 2022 TROA
REFUSAL PROCESSED BY IB
Jan 30, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 10, 2022 RFCS
REFUSAL PROCESSED BY MPU
Jan 10, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 19, 2021 RFCR
NON-FINAL ACTION WRITTEN
Dec 18, 2021 CNRT
ASSIGNED TO EXAMINER
Dec 15, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 8, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 2, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 27, 2021 REPR